New Drug Delivery Systems Market size to grow by USD 77.29 billion from 2021 to 2026, Driven by the rising prevalence of chronic diseases- Technavio

NEW YORK, April 4, 2023 /PRNewswire/ -- The global new drug delivery systems market size is estimated to grow by USD 77.29 billion from 2021 to 2026, according to Technavio. The market is estimated to grow at a CAGR of 6.08% during the forecast period. Factors such as the rising prevalence of chronic diseases, the growth in the biologics market, and digitalization in the healthcare system will drive the market, although challenges such as stringent regulations may hinder the market growth during the forecast period. For more insights on the forecast market size (2022 to 2026) - Request a sample report

New Drug Delivery Systems Market – Market Dynamics
Key factor driving market growth

• A major factor driving growth in the new drug delivery systems market is the rising prevalence of chronic diseases. 
• Since various biophysiological factors limit the efficacy of targeted therapy for chronic diseases such as diabetes, cancer, atherosclerosis, myocardial ischemia, asthma, pulmonary tuberculosis, Parkinson's disease, and Alzheimer's disease, many new drug delivery systems witness high demand to enhance drug efficacy.
• For instance, non-long-acting drug delivery systems (LADDS) treat chronic diseases, which deliver the drug molecules into target tissues either through systemic circulation or localized injections.
• Hence, the rising prevalence of diseases and increasing demand for an effective delivery system will boost market growth during the forecast period.

Leading trends influencing the market 

• The rising demand for various technologically advanced drug delivery systems with the increase in new diseases and efficient drug therapy is another factor supporting the new drug delivery systems market growth. 
• For example, nanochannel delivery system (nDS), a Bluetooth-enabled drug delivery technology, can be remotely controlled to administer the long-term delivery of drugs.
• Such new technologies can help maintain the appropriate drug concentration in the circulatory system and reduce treatment-monitoring clinical visits and follow-ups with healthcare providers.
• Thus, innovative drug delivery systems are estimated to drive the market growth.

Major challenges hindering the market growth

• Stringent regulations will be a primary challenge for the new drug delivery systems market during the forecast period.
• Regulatory authorities carefully study and evaluate drug-related data in terms of safety, efficacy, pharmacological data, pharmacodynamic effects, and drug interactions before approval.
• Thus, a drug that fails in any of these criteria is likely to receive a complete response letter (CRL) or may face complete rejection from regulatory agencies. 
• On receiving a CRL, a drug applicant is required to furnish additional data about the drug, which, in turn, may require additional clinical trials and increase the R&D expenditure of the drug. 
• Hence, stringent regulations may hinder the market growth of the new drug delivery systems market during the forecast period.

Insights on Market Drivers, trends, & Challenges and forecast period (2022 to 2026) - Request a sample report!

Why buy?

• Add credibility to strategy
• Analyzes competitor's offerings
• Get a holistic view of the market

Grow your profit margin with Technavio - buy the report!

New Drug Delivery Systems Market - Segmentation Assessment
Segment Overview
Technavio has segmented the market based on the route of administration (oral drug delivery systems, injectable drug delivery systems, pulmonary drug delivery systems, transdermal drug delivery systems, and others) and geography (North America, Europe, Asia, and the Rest of the World (ROW)). 

• The market share growth by the oral drug delivery systems segment will be significant for the growth of the new drug delivery systems during the forecast period. The oral route is the most common route for drug administration in the pharmaceutical industry because of its advantages, including a well-established delivery system, patient-friendly, convenient, cost-effective, and noninvasiveness. Therefore, the growth of the oral drug delivery systems segment impacts the growth of the new drug delivery system market during the forecast period.

Geography Overview
The report provides actionable insights and estimates the contribution of all regions to the growth of the global new drug delivery systems market.

• North America is estimated to account for 41% of the global new rug delivery system market growth during the forecast period. The US is the key market for new drug delivery systems in the region. Market growth in this region will be faster than the growth of the market in other regions. The growth can be attributed to factors such as the rising prevalence of chronic diseases, the presence of big pharmaceutical and biotechnical vendors, and high investment in the R&D of new drugs.

Insights on the market contribution of various segments, including country and region wise, and forecast market size (2022 to 2026) - Download a Sample Report

What are the key data covered in this New Drug Delivery Systems Market report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the new drug delivery systems market between 2022 and 2026
• Precise estimation of the size of the new drug delivery systems market and its contribution to the market with a focus on the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the new drug delivery systems market across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of new drug delivery systems market vendors

Gain instant access to 17,000+ market research reports. 

Technavio's SUBSCRIPTION platform

Related Reports:

The advanced drug delivery systems market size is expected to increase to USD 91.79 billion from 2021 to 2026. The growing chronic diseases are notably driving the advanced drug delivery systems market growth, although factors such as the presence of stringent regulations may impede the market growth.

The injectable drug delivery devices market size is expected to increase by USD 22.29 billion from 2021 to 2026. High growth potential in emerging countries is one of the key injectable drug delivery devices market trends supporting the market growth.

Browse for Technavio's Health Care Market Reports

Table of contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Route of Administration
• Exhibit 06: Executive Summary – Chart on Incremental Growth
• Exhibit 07: Executive Summary – Data Table on Incremental Growth
• Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 12: Market segments

• 3.3 Market size 2021

• 3.4 Market outlook: Forecast for 2021-2026 
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026

• 4.2 Bargaining power of buyers 
• Exhibit 18: Bargaining power of buyers – Impact of key factors in 2021 and 2026

• 4.3 Bargaining power of suppliers 
• Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

• 4.4 Threat of new entrants 
• Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

• 4.5 Threat of substitutes 
• Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Route of Administration

• 5.1 Market segments
• Exhibit 24: Chart on Route of Administration - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Route of Administration - Market share 2021-2026 (%)

• 5.2 Comparison by Route of Administration 
• Exhibit 26: Chart on Comparison by Route of Administration
• Exhibit 27: Data Table on Comparison by Route of Administration

• 5.3 Oral Drug Delivery Systems - Market size and forecast 2021-2026 
• Exhibit 28: Chart on Oral Drug Delivery Systems - Market size and forecast 2021-2026 ($ billion)
• Exhibit 29: Data Table on Oral Drug Delivery Systems - Market size and forecast 2021-2026 ($ billion)
• Exhibit 30: Chart on Oral Drug Delivery Systems - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Oral Drug Delivery Systems - Year-over-year growth 2021-2026 (%)

• 5.4 Injectable Drug Delivery Systems - Market size and forecast 2021-2026 
• Exhibit 32: Chart on Injectable Drug Delivery Systems - Market size and forecast 2021-2026 ($ billion)
• Exhibit 33: Data Table on Injectable Drug Delivery Systems - Market size and forecast 2021-2026 ($ billion)
• Exhibit 34: Chart on Injectable Drug Delivery Systems - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Injectable Drug Delivery Systems - Year-over-year growth 2021-2026 (%)

• 5.5 Pulmonary Drug Delivery Systems - Market size and forecast 2021-2026 
• Exhibit 36: Chart on Pulmonary Drug Delivery Systems - Market size and forecast 2021-2026 ($ billion)
• Exhibit 37: Data Table on Pulmonary Drug Delivery Systems - Market size and forecast 2021-2026 ($ billion)
• Exhibit 38: Chart on Pulmonary Drug Delivery Systems - Year-over-year growth 2021-2026 (%)
• Exhibit 39: Data Table on Pulmonary Drug Delivery Systems - Year-over-year growth 2021-2026 (%)

• 5.6 Transdermal Drug Delivery Systems - Market size and forecast 2021-2026 
• Exhibit 40: Chart on Transdermal Drug Delivery Systems - Market size and forecast 2021-2026 ($ billion)
• Exhibit 41: Data Table on Transdermal Drug Delivery Systems - Market size and forecast 2021-2026 ($ billion)
• Exhibit 42: Chart on Transdermal Drug Delivery Systems - Year-over-year growth 2021-2026 (%)
• Exhibit 43: Data Table on Transdermal Drug Delivery Systems - Year-over-year growth 2021-2026 (%)

• 5.7 Others - Market size and forecast 2021-2026 
• Exhibit 44: Chart on Others - Market size and forecast 2021-2026 ($ billion)
• Exhibit 45: Data Table on Others - Market size and forecast 2021-2026 ($ billion)
• Exhibit 46: Chart on Others - Year-over-year growth 2021-2026 (%)
• Exhibit 47: Data Table on Others - Year-over-year growth 2021-2026 (%)

• 5.8 Market opportunity by Route of Administration 
• Exhibit 48: Market opportunity by Route of Administration ($ billion)

6 Customer Landscape

• 6.1 Customer landscape overview 
• Exhibit 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation 
• Exhibit 50: Chart on Market share by geography 2021-2026 (%)
• Exhibit 51: Data Table on Market share by geography 2021-2026 (%)

• 7.2 Geographic comparison 
• Exhibit 52: Chart on Geographic comparison
• Exhibit 53: Data Table on Geographic comparison

• 7.3 North America - Market size and forecast 2021-2026 
• Exhibit 54: Chart on North America - Market size and forecast 2021-2026 ($ billion)
• Exhibit 55: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
• Exhibit 56: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on North America - Year-over-year growth 2021-2026 (%)

• 7.4 Europe - Market size and forecast 2021-2026 
• Exhibit 58: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
• Exhibit 59: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
• Exhibit 60: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on Europe - Year-over-year growth 2021-2026 (%)

• 7.5 Asia - Market size and forecast 2021-2026 
• Exhibit 62: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
• Exhibit 63: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
• Exhibit 64: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on Asia - Year-over-year growth 2021-2026 (%)

• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026 
• Exhibit 66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
• Exhibit 67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
• Exhibit 68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

• 7.7 US - Market size and forecast 2021-2026 
• Exhibit 70: Chart on US - Market size and forecast 2021-2026 ($ billion)
• Exhibit 71: Data Table on US - Market size and forecast 2021-2026 ($ billion)
• Exhibit 72: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on US - Year-over-year growth 2021-2026 (%)

• 7.8 Germany - Market size and forecast 2021-2026 
• Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
• Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
• Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)

• 7.9 UK - Market size and forecast 2021-2026 
• Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ billion)
• Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
• Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)

• 7.10 China - Market size and forecast 2021-2026 
• Exhibit 82: Chart on China - Market size and forecast 2021-2026 ($ billion)
• Exhibit 83: Data Table on China - Market size and forecast 2021-2026 ($ billion)
• Exhibit 84: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 85: Data Table on China - Year-over-year growth 2021-2026 (%)

• 7.11 Japan - Market size and forecast 2021-2026 
• Exhibit 86: Chart on Japan - Market size and forecast 2021-2026 ($ billion)
• Exhibit 87: Data Table on Japan - Market size and forecast 2021-2026 ($ billion)
• Exhibit 88: Chart on Japan - Year-over-year growth 2021-2026 (%)
• Exhibit 89: Data Table on Japan - Year-over-year growth 2021-2026 (%)

• 7.12 Market opportunity by geography 
• Exhibit 90: Market opportunity by geography ($ billion)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers

• 8.2 Market challenges

• 8.3 Impact of drivers and challenges 
• Exhibit 91: Impact of drivers and challenges in 2021 and 2026

• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview

• 9.2 Vendor landscape
• Exhibit 92: Overview on Criticality of inputs and Factors of differentiation

• 9.3 Landscape disruption
• Exhibit 93: Overview on factors of disruption

• 9.4 Industry risks
• Exhibit 94: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 95: Vendors covered

• 10.2 Market positioning of vendors 
• Exhibit 96: Matrix on vendor position and classification

• 10.3 Baxter International Inc. 
• Exhibit 97: Baxter International Inc. - Overview
• Exhibit 98: Baxter International Inc. - Business segments
• Exhibit 99: Baxter International Inc. - Key offerings
• Exhibit 100: Baxter International Inc. - Segment focus

• 10.4 Becton Dickinson and Co. 
• Exhibit 101: Becton Dickinson and Co. - Overview
• Exhibit 102: Becton Dickinson and Co. - Business segments
• Exhibit 103: Becton Dickinson and Co. - Key offerings
• Exhibit 104: Becton Dickinson and Co. - Segment focus

• 10.5 F. Hoffmann-La Roche Ltd. 
• Exhibit 105: F. Hoffmann-La Roche Ltd. - Overview
• Exhibit 106: F. Hoffmann-La Roche Ltd. - Business segments
• Exhibit 107: F. Hoffmann-La Roche Ltd. - Key news
• Exhibit 108: F. Hoffmann-La Roche Ltd. - Key offerings
• Exhibit 109: F. Hoffmann-La Roche Ltd. - Segment focus

• 10.6 Gerresheimer AG
• Exhibit 110: Gerresheimer AG - Overview
• Exhibit 111: Gerresheimer AG - Business segments
• Exhibit 112: Gerresheimer AG - Key offerings
• Exhibit 113: Gerresheimer AG - Segment focus

• 10.7 Kindeva Drug Delivery L.P. 
• Exhibit 114: Kindeva Drug Delivery L.P. - Overview
• Exhibit 115: Kindeva Drug Delivery L.P. - Product / Service
• Exhibit 116: Kindeva Drug Delivery L.P. - Key news
• Exhibit 117: Kindeva Drug Delivery L.P. - Key offerings

• 10.8 Medtronic Plc
• Exhibit 118: Medtronic Plc - Overview
• Exhibit 119: Medtronic Plc - Business segments
• Exhibit 120: Medtronic Plc - Key offerings
• Exhibit 121: Medtronic Plc - Segment focus

• 10.9 Nemera
• Exhibit 122: Nemera - Overview
• Exhibit 123: Nemera - Product / Service
• Exhibit 124: Nemera - Key news
• Exhibit 125: Nemera - Key offerings

• 10.10 Pfizer Inc.
• Exhibit 126: Pfizer Inc. - Overview
• Exhibit 127: Pfizer Inc. - Business segments
• Exhibit 128: Pfizer Inc. - Key news
• Exhibit 129: Pfizer Inc. - Key offerings
• Exhibit 130: Pfizer Inc. - Segment focus

• 10.11 West Pharmaceutical Services Inc. 
• Exhibit 131: West Pharmaceutical Services Inc. - Overview
• Exhibit 132: West Pharmaceutical Services Inc. - Business segments
• Exhibit 133: West Pharmaceutical Services Inc. - Key offerings
• Exhibit 134: West Pharmaceutical Services Inc. - Segment focus

• 10.12 Ypsomed Holding AG
• Exhibit 135: Ypsomed Holding AG - Overview
• Exhibit 136: Ypsomed Holding AG - Business segments
• Exhibit 137: Ypsomed Holding AG - Key offerings
• Exhibit 138: Ypsomed Holding AG - Segment focus

11 Appendix

• 11.1 Scope of the report

• 11.2 Inclusions and exclusions checklist 
• Exhibit 139: Inclusions checklist

• 11.3 Currency conversion rates for US$ 
• Exhibit 140: Currency conversion rates for US$

• 11.4 Research methodology
• Exhibit 141: Research methodology
• Exhibit 142: Validation techniques employed for market sizing
• Exhibit 143: Information sources

• 11.5 List of abbreviations 
• Exhibit 144: List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio